Crabs cross a road in Giron, Cuba, Sunday, April 10, 2022. Millions of crabs emerge at the beginning of the spring rains and start a journey to the waters of the Bay of Pigs to spawn in a yearly migration. (AP Photo/Ramon Espinosa)
Every year in Cuba, millions of crabs emerge from the forest at the beginning of the spring rains and head for the waters of the Bay of Pigs, crossing streets and highways on a perilous journey to mate and reproduce.
Now underway, the migration causes concern to drivers who try to swerve in an often futile attempt not to kill the crustaceans. The crabs are a nuisance to residents but the sight of their road-crossing is a wonder for tourists and other first-time onlookers.
“They got here before us,” said Amaury Urra, a 50-year-old hiking guide who spent his entire life in this part of the Ciénega de Zapata, the largest wetland in the Caribbean, particularly picturesque for the backdrop of turquoise sea waters and the coastal cliffs. ″We’re used to this.″
“Where I live, which is in the center of the town of Girón, the crabs don’t get there as much,″ though there are plenty on the outskirts, he said.
Located about 180 kilometers (110 miles) southeast of Havana, the area was the scene of a 1961 failed invasion by Cuban exiles who signed up for a covertly CIA-funded operation to overthrow Fidel Castro.
This year, the crabs started their journey early. At the end of March, the municipal authorities issued a warning to drivers to avoid traveling in the morning and evening hours - the favorite crossing times for the crabs. Environmentalists usually demand the closure of the main road, especially at key migration times.
The passage of the red crustaceans — the species is called gecarcinus ruricola — could last until July. The largest amount of traffic occurs between April and May. Residents have to be careful: When the crabs feel threatened, they can puncture car tires with their pincers.
Official figures estimate that some 3.5 million crabs die each season on the road, many crushed by passing vehicles. They take a minute and a half to cross.
This type of crab lives and migrates in the Bahamas, Nicaragua, Jamaica and Dominica. But only here, and perhaps in another sector of the coast towards the neighboring province of Cienfuegos, does its path collide so dramatically with human traffic.
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home.
Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
Direct health care company Nomi Health recently raised $110 million in a Series A round. Nomi Health lets public and private organizations directly purchase healthcare at reduced costs, and pay providers in real-time. It also delivers healthcare directly to under-served communities via its fleet of mobile care units, which the company says is the largest in the country. Nomi Health says its mission is to improve the health care experience for all Americans. Nomi Health CEO Mark Newman joined Cheddar News' Closing Bell to discuss.
The airline industry says it is contending with staff shortages that threaten to hamper operations amid the COVID resurgence, andDelta Airlines CEO Ed Bastian called on the CDC to revise its guidance for vaccinated workers who test positive from a 10-day quarantine to just five. Chuck Liberman, chief investment officer and managing partner at Advisors Capital Management LLC, joined Cheddar to talk about the current guidance on isolation and why he believes the omicron variant calls for more relaxed guidance given its reportedly mild symptoms.
The boys discuss President Biden's plans to send out free rapid tests as the testing supply chain starts to buckle ahead of the holidays. Also, why aren't Americans having more babies, and The Matrix returns.
NASA is launching its new generation of space telescopes just before Christmas. The James Webb Space Telescope, set to launch on December 24th, will succeed the Hubble space telescope as the world's most powerful complex space observatory. The project has been 30 years in the making and is one of the most highly anticipated space science missions of the 21st century. Klaus Pontoppidan, astronomer and JWST Project Scientist at the Space Telescope Science Institute joined Cheddar's Opening Bell to discuss.
With Omicron becoming the dominant COVID-19 variant in the U.S., President Joe Biden announced that he will make 500 million rapid tests available to Americans in January 2022. Cheddar News speaks with Dr. Shereef Elnahal, President and CEO of University Hospital why testing is key to combatting the spread of the virus.
